世界の豚用ワクチン市場2021-2028:製品別(組換え、不活化)、種類別(仮性狂犬病、豚サーコウイルス2型)、地域別(アジア太平洋、北米)

【英語タイトル】Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Recombinant, Inactivated), By Type (Pseudorabies, Porcine Circovirus Type 2), By Region (Asia Pacific, North America), And Segment Forecasts, 2021 - 2028

Grand View Researchが出版した調査資料(GV22JA008)・商品コード:GV22JA008
・発行会社(調査会社):Grand View Research
・発行日:2022年1月4日
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥833,000見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥973,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,253,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、世界の豚用ワクチン市場規模が2021年から2028年までの間に年平均4.9%成長し、2028年までに20.9億ドルに達すると予測しています。本調査レポートは、豚用ワクチンの世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、新型コロナウイルス感染症の影響分析、種類別(豚インフルエンザ、豚コレラ、豚パルボウイルス、豚サーコウイルス2型、M.Hyo)分析、製品別(弱毒生ワクチン、不活化ワクチン、サブユニットワクチン、DNAワクチン、組換えワクチン)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・新型コロナウイルス感染症の影響分析
・世界の豚用ワクチン市場規模:種類別(豚インフルエンザ、豚コレラ、豚パルボウイルス、豚サーコウイルス2型、M.Hyo)
・世界の豚用ワクチン市場規模:製品別(弱毒生ワクチン、不活化ワクチン、サブユニットワクチン、DNAワクチン、組換えワクチン)
・世界の豚用ワクチン市場規模:地域別
・競争状況
・企業情報
❖ レポートの概要 ❖

Swine Vaccines Market Growth & Trends

The global swine vaccines market size is expected to reach USD 2.09 billion by 2028, registering a CAGR of 4.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.

The COVID-19 pandemic directly or indirectly impacted the business, results of operations, and financial conditions of market players. The Animal Health business was confronted with various production and supply bottlenecks because of the COVID-19 pandemic; this consists of delays in the delivery of raw materials and active ingredients and capacity constraints in freight transport (especially air and sea freight). While on the other side, the industry has expanded its research at an unprecedented pace in animal health. Thereby, the COVID-19 pandemic significantly impacted the market growth.

In addition, the growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine. Stating that it has introduced the product under the brand name ‘Raksha Class’. This is a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players are involved in strategic initiatives, such as joint ventures, mergers, acquisitions, and new product launches to gain a higher market share. For instance, in February 2020, the new vaccine created by ICAR, Indian Veterinary Research Institute (IVRI), based in Uttar Pradesh, was much cheaper than an already existing one. It costs only Rs 2 for each dose over the present vaccine’s rate of Rs 15-20 for each dose and an imported Korean vaccine rate of Rs 30 for each dose.

Swine Vaccines Market Report Highlights

• The inactivated vaccines segment dominated the market in 2020 owing to its easy availability and low cost over others

• A recombinant vaccine is expected to register the fastest CAGR over the forecast period owing to the benefits, such as enhanced effectiveness, technology advancement, and increased long-standing prevention

• The Porcine circovirus type 2 segment dominated the market in 2020 due to the increased prevalence of the disease. Moreover, this is the quickly mutating of all single-stranded DNA (ssDNA) viruses, therefore it has a great mutation and recombination rate

• Asia Pacific is expected to register the fastest CAGR over the forecast period due to the growing cases of infectious diseases in swine, increasing awareness about animal health, rising demand for animal protein, and rapid urbanization

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Summary, 2020
Chapter 3. Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Swine Vaccines Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Swine Vaccines Industry Analysis – Porter’s
3.4.1. Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5. Swine Vaccines Industry Analysis – PEST
3.5.1. Political & Legal Landscape
3.5.2. Economic Landscape
3.5.3. Social Landscape
3.5.4. Technology Landscape
3.6. Regulatory Framework
Chapter 4. Impact of COVID-19 on Swine Vaccines Market
4.1. Disease Prevalence Analysis
4.2. Covid-19 Impact and Future Scenario
4.3. Strategies Implemented by Companies
4.4. Impact on Market Players
Chapter 5. Swine Vaccines Market : Type Estimates & Trend Analysis
5.1. Type Movement Analysis & Market Share, 2020 & 2028
5.2. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
5.2.1. Swine Influenza
5.2.2. Classical Swine Fever
5.2.3. Porcine Parvovirus
5.2.4. Porcine Circovirus Type 2
5.2.5. M.Hyo
5.2.6. Actinobacillus Pleuropneumonia
5.2.7. PRRS
5.2.8. Foot & Mouth Disease
5.2.9. Pseudorabies
5.2.10. PEDV
5.2.11. Others
Chapter 6. Swine Vaccines Market : Product Estimates & Trend Analysis
6.1. Product Movement Analysis & Market Share, 2020 & 2028
6.2. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
6.2.1 Attenuated Live Vaccines
6.2.2 Inactivated Vaccines
6.2.3 Subunit Vaccines
6.2.4 DNA Vaccines
6.2.5 Recombinant Vaccines
Chapter 7. Swine Vaccines Market : Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2020 & 2028
7.2. Market Share Analysis, by Region
7.3. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
7.3.1. North America
7.3.1.1. U.S.
7.3.1.2. Canada
7.3.2. Europe
7.3.2.1. U.K.
7.3.2.2. Germany
7.3.2.3. France
7.3.2.4. Italy
7.3.2.5. Spain
7.3.3. Asia Pacific
7.3.3.1. Japan
7.3.3.2. China
7.3.3.3. India
7.3.4. Latin America
7.3.4.1. Brazil
7.3.4.2. Mexico
7.3.4.3 Argentina
7.3.5. Middle East & Africa
7.3.5.1. South Africa
7.3.5.2 Saudi Arabia
Chapter 8. Competitive Landscape
8.1. Market Participation Categorization
8.2. Public Companies
8.2.1. Company Market Share/Position Analysis
8.2.2. Heat Map Analysis
8.3. Private Companies
8.3.1. List of Key Companies
Chapter 9. Company Profiles
9.1. Company Profiles
9.1.1. Merck Animal Health
9.1.1.1. Company Overview
9.1.1.2. Financial Performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Ceva Sante Animale
9.1.2.1. Company Overview
9.1.2.2. Financial Performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Zoetis
9.1.3.1. Company Overview
9.1.3.2. Financial Performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Boehringer Ingelheim GmbH
9.1.4.1. Company Overview
9.1.4.2. Financial Performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Elanco
9.1.5.1. Company Overview
9.1.5.2. Financial Performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Indian Immunologicals Ltd.
9.1.6.1. Company Overview
9.1.6.2. Financial Performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Biogenesis Bagó
9.1.7.1. Company Overview
9.1.7.2. Financial Performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Phibro Animal Health
9.1.8.1. Company Overview
9.1.8.2. Financial Performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. KM Biologics
9.1.9.1. Company Overview
9.1.9.2. Financial Performance
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. HIPRA
9.1.10.1. Company Overview
9.1.10.2. Financial Performance
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 North America Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 3 North America Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 4 The U.S. Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 5 The U.S. Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 6 Canada Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 7 Canada Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 8 Europe Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 9 Europe Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 10 U.K. Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 11 U.K. Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 12 Germany Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 13 Germany Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 14 France Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 15 France Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 16 Italy Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 17 Italy Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 18 Spain Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 19 Spain Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 20 Asia Pacific Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 21 Asia Pacific Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 22 Japan Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 23 Japan Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 24 China Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 25 China Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 26 India Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 27 India Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 28 Latin America Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 29 Latin America Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 30 Brazil Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 31 Brazil Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 32 Mexico Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 33 Mexico Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 34 Argentina Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 35 Argentina Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 36 MEA Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 37 MEA Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 38 South Africa Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 39 South Africa Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)
Table 40 Saudi Arabia Swine Vaccines market revenues, by type, 2016 - 2028 (Revenue, USD Million)
Table 41 Saudi Arabia Swine Vaccines market revenues, by product, 2016 - 2028 (Revenue, USD Million)


List of Figures

Fig. 1 Swine Vaccines Segmentation and Scope
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Market snapshot, 2020 (USD Million)
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Swine Vaccines market: Type movement analysis
Fig. 13 Swine Vaccines market type outlook: Key takeaways
Fig. 14 Swine Influenza
Fig. 15 Classical Swine Fever
Fig. 16 Porcine Parvovirus
Fig. 17 Porcine Circovirus Type 2
Fig. 18 M.Hyo
Fig. 19 Actinobacillus Pleuropneumonia
Fig. 20 PRRS
Fig. 21 Foot & Mouth Disease
Fig. 22 Pseudorabies
Fig. 23 PEDV
Fig. 24 Others, 2016 - 2028 (USD Million)
Fig. 25 Swine Vaccines market: Product movement analysis
Fig. 26 Swine Vaccines market product outlook: Key takeaways
Fig. 27 Attenuated Live Vaccines
Fig. 28 Inactivated Vaccines
Fig. 29 Subunit Vaccines
Fig. 30 DNA Vaccines
Fig. 31 Recombinant Vaccines, 2016 - 2028 (USD Million)
Fig. 32 Swine Vaccines market: Regional movement analysis
Fig. 33 Regional marketplace: Key takeaways
Fig. 34 North America Swine Vaccines market, by country, 2016 - 2028 (USD Million)
Fig. 35 The U.S. Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 36 Canada Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 37 Europe Swine Vaccines market, by country, 2016 - 2028 (USD Million)
Fig. 38 U.K. Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 39 Germany Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 40 France Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 41 Italy Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 42 Spain Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 43 Asia Pacific Swine Vaccines market, by country, 2016 - 2028 (USD Million)
Fig. 44 Japan implantation Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 45 China Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 46 India Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 47 Latin America Swine Vaccines market, by country, 2016 - 2028 (USD Million)
Fig. 48 Brazil Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 49 Mexico Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 49 Argentina Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 50 MEA Swine Vaccines market, by country, 2016 - 2028 (USD Million)
Fig. 51 South Africa Swine Vaccines market, 2016 - 2028 (USD Million)
Fig. 52 Saudi Arabia Swine Vaccines market, 2016 - 2028 (USD Million)

★調査レポート[世界の豚用ワクチン市場2021-2028:製品別(組換え、不活化)、種類別(仮性狂犬病、豚サーコウイルス2型)、地域別(アジア太平洋、北米)] (コード:GV22JA008)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の豚用ワクチン市場2021-2028:製品別(組換え、不活化)、種類別(仮性狂犬病、豚サーコウイルス2型)、地域別(アジア太平洋、北米)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆